Pure Global

“DAKO” PD-L1 IHC 22C3 pharmDx - Taiwan Registration 5e0549c5e21bac509c8f434821edf547

Access comprehensive regulatory information for “DAKO” PD-L1 IHC 22C3 pharmDx in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5e0549c5e21bac509c8f434821edf547 and manufactured by Agilent Technologies, Inc.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5e0549c5e21bac509c8f434821edf547
Registration Details
Taiwan FDA Registration: 5e0549c5e21bac509c8f434821edf547
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“DAKO” PD-L1 IHC 22C3 pharmDx
TW: “達克” PD-L1免疫組織化學染色22C3檢測套組
Risk Class 3
MD

Registration Details

5e0549c5e21bac509c8f434821edf547

Ministry of Health Medical Device Import No. 028961

DHA05602896109

Company Information

United States

Product Details

Efficacy changed to (cancellation of tumor indication - uroepithelial carcinoma): detailed as approved Chinese instructions.

B Hematology and pathology devices

B1860 Immunopathological histochemical reagents and kits

Imported from abroad

Dates and Status

Nov 24, 2016

Nov 24, 2026